Skip to content

Join our community and subscribe to our free weekly newsletter

Subscribe
  • Latest News
    • Articles
    • Live Talks
    • Trials Update
  • Prevention & Risk Factors
    • Science-Backed Dementia Prevention
    • Alzheimer’s Genetics & Risk Factors
    • Menopause
    • Long COVID
  • Dementias
    • Alzheimer’s Disease
    • Vascular Dementia
    • Frontotemporal Dementia (FTD)
    • Lewy Body Dementia
    • Traumatic Brain Injury & CTE
  • Brain Disorders
    • Mild Cognitive Impairment (MCI)
    • Parkinson’s Disease
  • Getting Diagnosed
    • Diagnosis
    • Journey to Diagnosis
    • Genetic Testing
    • Alzheimer’s Biomarkers
    • Diversity and Dementia
  • Caregivers
    • Caregiver Voices
  • Learning Guides

Simon Spichak, MSc

  • brain-computer interface, Parkinson's, ALS

    Mind Control: Bluetooth, Brain Health, and Digital Devices

  • Amylyx Pharmaceuticals AMX0035 for Alzheimer's

    Eisai Seeks Accelerated Approval for Alzheimer’s Drug Lecanemab

  • Cassava Simufilam, Cassava Sciences, Remi Barbier

    Cassava’s Simufilam Trial Data Still Under Scrutiny

  • photobiomodulation device

    Review: These Devices Use Flashing Lights Designed to Boost Brain Health

  • microbiome aging, microscopic organisms

    The Gut Microbiome in Aging and Cognitive Health

  • dementia clinical trials, simufilam dementia, cassava, remi barbier

    Cassava Rebukes Fraud Allegations, Faces Calls to Halt Alzheimer’s Drug Phase III Trials

  • Razadyne galantamine for alzheimers

    Renewed Interest for Galantamine, an 18-Year-Old Alzheimer’s Drug

  • Bio-Hermes study, diagnostics, blood test, retinal scan

    Bio-Hermes Study Underway To Develop Cost-Effective Alzheimer’s Diagnostics

  • simufilam dementia, cassava, remi barbier

    Cassava’s Data on Simufilam Looks Promising—Experts Say Too Soon to Know

  • aduhelm drug, aducanumab, alzheimer's treatment - fda aduhelm investigation

    FDA Head Calls for Investigation Into Controversial Aduhelm Approval

Previous2930

Sign up for our weekly newsletter

Subscribe to get the latest and most trusted brain health science and news, straight to your inbox.

Sign Up

Copyright © 2026 Being Patient

Join Our Community

Get brain health and dementia news, storytelling, and expert insights right to your inbox. Sign up for our free weekly newsletter.

You're in! Thanks for subscribing — our free weekly newsletter is coming your way.
You’re already subscribed to our newsletter.

About Being Patient

  • Advisors
  • Contribute
  • About Us
  • Partnerships
  • Contact Us
  • Press
  • Glossary

Legal

  • Terms & Conditions
  • Privacy Policy
  • AI Policy
  • Republishing Our Content
Copyright © 2026 Being Patient

Social Media

  • Instagram 
  • Facebook
  • LinkedIn
  • YouTube
  • TikTok
  • X
Copyright © 2026 Being Patient

Page load link
Go to Top